Rotenone-exposure as cytofunctional aging model of human dermal fibroblast prior replicative senescence.


Journal

Toxicology in vitro : an international journal published in association with BIBRA
ISSN: 1879-3177
Titre abrégé: Toxicol In Vitro
Pays: England
ID NLM: 8712158

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 12 03 2023
revised: 26 06 2023
accepted: 29 06 2023
medline: 14 7 2023
pubmed: 3 7 2023
entrez: 2 7 2023
Statut: ppublish

Résumé

Rotenone (Ro), causes superoxide imbalance by inhibiting complex I of the mitochondrial electron transport chain, being able to serve as a model for functional skin aging by inducing cytofunctional changes in dermal fibroblasts prior to proliferative senescence. To test this hypothesis, we conducted an initial protocol to select a concentration of Ro (0.5, 1, 1.5, 2, 2.5, and 3 μM) that would induce the highest levels of the aging marker beta-galactosidase (β-gal) in human dermal HFF-1 fibroblasts after 72 h of culture, as well as a moderate increase in apoptosis and partial G1 arrestment. We evaluated whether the selected concentration (1 μM) differentially modulated oxidative and cytofunctional markers of fibroblasts. Ro 1.0 μM increased β-gal levels and apoptosis frequency, decreased the frequency of S/G2 cells, induced higher levels of oxidative markers, and presented a genotoxic effect. Fibroblasts exposed to Ro showed lower mitochondrial activity, extracellular collagen deposition, and fewer fibroblast cytoplasmic connections than controls. Ro triggered overexpression of the gene associated with aging (MMP-1), downregulation genes of collagen production (COL1A, FGF-2), and cellular growth/regeneration (FGF-7). The 1 μM concentration of Ro could serve as an experimental model for functional aging fibroblasts prior to replicative senescence. It could be used to identify causal aging mechanisms and strategies to delay skin aging events.

Identifiants

pubmed: 37394047
pii: S0887-2333(23)00086-3
doi: 10.1016/j.tiv.2023.105637
pii:
doi:

Substances chimiques

Rotenone 03L9OT429T
Collagen 9007-34-5

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

105637

Informations de copyright

Copyright © 2023 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflicts of interest. The authors alone are responsible for the content and writing of the article.

Auteurs

Ivana Beatrice Mânica da Cruz (IBM)

Postgraduate Program of Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Postgraduate Program of em Gerontology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Open University of the Third Age, Manaus, AM, Brazil.

Nathália Cardoso de Afonso Bonotto (NC)

Postgraduate Program of Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Postgraduate Program of em Gerontology, Federal University of Santa Maria, Santa Maria, RS, Brazil.

Bárbara Osmarin Turra (BO)

Postgraduate Program of Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Open University of the Third Age, Manaus, AM, Brazil.

Cibele Ferreira Teixeira (CF)

Postgraduate Program of Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil.

Verônica Farina Azzolin (VF)

Postgraduate Program of em Gerontology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Open University of the Third Age, Manaus, AM, Brazil.

Ednea Aguiar Maia Ribeiro (EAM)

Open University of the Third Age, Manaus, AM, Brazil.

Jacqueline Da Costa Escobar Piccoli (JDCE)

Federal University of Pampa - Campus Uruguaiana, Uruguaiana, Brazil.

Fernanda Barbisan (F)

Postgraduate Program of Pharmacology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Postgraduate Program of em Gerontology, Federal University of Santa Maria, Santa Maria, RS, Brazil; Open University of the Third Age, Manaus, AM, Brazil. Electronic address: fernandabarbisan@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH